ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

Future Oncology, Ahead of Print.

Source: Future Oncology - March 23, 2020 Category: Cancer & Oncology Authors: Peter Hillmen Jennifer R Brown Barbara F Eichhorst Nicole Lamanna Susan M O ’Brien Lugui Qiu Tommi Salmi James Hilger Kenneth Wu Aileen Cohen Jane Huang Constantine S Tam Source Type: research